These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

265 related items for PubMed ID: 15325939

  • 1. Lipid-altering changes and pleiotropic effects of atorvastatin in patients with hypercholesterolemia.
    Sakabe K, Fukuda N, Wakayama K, Nada T, Shinohara H, Tamura Y.
    Am J Cardiol; 2004 Aug 15; 94(4):497-500. PubMed ID: 15325939
    [Abstract] [Full Text] [Related]

  • 2. Short-term effects of low-dose atorvastatin on inflammatory status and lipid profiles in perimenopausal hypercholesterolemic, hypertriglyceridemic women.
    Ushiroyama T, Nosaka S, Ueki M.
    Int J Cardiol; 2006 Oct 26; 113(1):66-75. PubMed ID: 16356567
    [Abstract] [Full Text] [Related]

  • 3. Gender differences in short-term effects of atorvastatin on lipid profile, fibrinolytic parameters, and endothelial function.
    Sakabe K, Fukuda N, Fukuda Y, Wakayama K, Nada T, Morishita S, Shinohara H, Tamura Y.
    Nutr Metab Cardiovasc Dis; 2008 Mar 26; 18(3):182-8. PubMed ID: 17399968
    [Abstract] [Full Text] [Related]

  • 4. Comparison of the efficacy and tolerability of pitavastatin and atorvastatin: an 8-week, multicenter, randomized, open-label, dose-titration study in Korean patients with hypercholesterolemia.
    Lee SH, Chung N, Kwan J, Kim DI, Kim WH, Kim CJ, Kim HS, Park SH, Seo HS, Shin DG, Shin YW, Shim WJ, Ahn TH, Ho Yun K, Yoon MH, Cha KS, Choi SW, Han SW, Hyon MS.
    Clin Ther; 2007 Nov 26; 29(11):2365-73. PubMed ID: 18158077
    [Abstract] [Full Text] [Related]

  • 5. Beneficial effects of atorvastatin on sd LDL and LDL phenotype B in statin-naive patients and patients previously treated with simvastatin or pravastatin.
    Baldassarre S, Scruel O, Deckelbaum RJ, Dupont IE, Ducobu J, Carpentier YA.
    Int J Cardiol; 2005 Oct 10; 104(3):338-45. PubMed ID: 16186066
    [Abstract] [Full Text] [Related]

  • 6. Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterolemia: additional results from the STELLAR trial.
    Jones PH, Hunninghake DB, Ferdinand KC, Stein EA, Gold A, Caplan RJ, Blasetto JW, Statin Therapies for Elevated Lipid Levels Compared Across Doses to Rosuvastatin Study Group.
    Clin Ther; 2004 Sep 10; 26(9):1388-99. PubMed ID: 15531001
    [Abstract] [Full Text] [Related]

  • 7. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
    Sasaki J, Ikeda Y, Kuribayashi T, Kajiwara K, Biro S, Yamamoto K, Ageta M, Kobori S, Saikawa T, Otonari T, Kono S.
    Clin Ther; 2008 Jun 10; 30(6):1089-101. PubMed ID: 18640465
    [Abstract] [Full Text] [Related]

  • 8. Effect of atorvastatin on blood lipid levels in the first 2 weeks of treatment: a randomized, placebo-controlled study.
    Schrott HG, Knapp H, Davila M, Shurzinske L, Black D.
    Am Heart J; 2000 Aug 10; 140(2):249-52. PubMed ID: 10925339
    [Abstract] [Full Text] [Related]

  • 9. Achieving lipoprotein goals in patients at high risk with severe hypercholesterolemia: efficacy and safety of ezetimibe co-administered with atorvastatin.
    Stein E, Stender S, Mata P, Sager P, Ponsonnet D, Melani L, Lipka L, Suresh R, Maccubbin D, Veltri E, Ezetimibe Study Group.
    Am Heart J; 2004 Sep 10; 148(3):447-55. PubMed ID: 15389231
    [Abstract] [Full Text] [Related]

  • 10. The DISCOVERY PENTA study: a DIrect Statin COmparison of LDL-C Value--an Evaluation of Rosuvastatin therapY compared with atorvastatin.
    Fonseca FA, Ruiz A, Cardona-Muñoz EG, Silva JM, Fuenmayor N, Marotti M, DISCOVERY PENTA investigators.
    Curr Med Res Opin; 2005 Aug 10; 21(8):1307-15. PubMed ID: 16083541
    [Abstract] [Full Text] [Related]

  • 11. Effects of atorvastatin and atorvastatin withdrawal on soluble CD40L and adipocytokines in patients with hypercholesterolaemia.
    Chu CS, Lee KT, Lee MY, Su HM, Voon WC, Sheu SH, Lai WT.
    Acta Cardiol; 2006 Jun 10; 61(3):263-9. PubMed ID: 16869445
    [Abstract] [Full Text] [Related]

  • 12. Time course differences for statin-induced pleiotropic effects in hypercholesterolemic patients.
    Sakabe K, Fukuda N, Wakayama K, Nada T, Shinohara H, Tamura Y.
    Int J Cardiol; 2004 Mar 10; 94(1):111-7. PubMed ID: 14996484
    [Abstract] [Full Text] [Related]

  • 13. Twelve-week, multicenter, randomized, open-label comparison of the effects of rosuvastatin 10 mg/d and atorvastatin 10 mg/d in high-risk adults: a DISCOVERY study.
    Strandberg TE, Feely J, Sigurdsson EL, DISCOVERY study group.
    Clin Ther; 2004 Nov 10; 26(11):1821-33. PubMed ID: 15639694
    [Abstract] [Full Text] [Related]

  • 14. Influence of withdrawal of statin treatment on proinflammatory response and fibrinolytic activity in humans: an effect independent on cholesterol elevation.
    Lai WT, Lee KT, Chu CS, Voon WC, Yen HW, Tsai LY, Sheu SH.
    Int J Cardiol; 2005 Feb 28; 98(3):459-64. PubMed ID: 15708180
    [Abstract] [Full Text] [Related]

  • 15. Comparison of rosuvastatin with atorvastatin, simvastatin and pravastatin in achieving cholesterol goals and improving plasma lipids in hypercholesterolaemic patients with or without the metabolic syndrome in the MERCURY I trial.
    Stender S, Schuster H, Barter P, Watkins C, Kallend D, MERCURY I Study Group.
    Diabetes Obes Metab; 2005 Jul 28; 7(4):430-8. PubMed ID: 15955130
    [Abstract] [Full Text] [Related]

  • 16. The efficacy of statin monotherapy uptitration versus switching to ezetimibe/simvastatin: results of the EASEGO study.
    Roeters van Lennep HW, Liem AH, Dunselman PH, Dallinga-Thie GM, Zwinderman AH, Jukema JW.
    Curr Med Res Opin; 2008 Mar 28; 24(3):685-94. PubMed ID: 18226326
    [Abstract] [Full Text] [Related]

  • 17. Effect of atorvastatin therapy and conversion to tacrolimus on hypercholesterolemia and endothelial dysfunction after renal transplantation.
    Wissing KM, Unger P, Ghisdal L, Broeders N, Berkenboom G, Carpentier Y, Abramowicz D.
    Transplantation; 2006 Sep 27; 82(6):771-8. PubMed ID: 17006324
    [Abstract] [Full Text] [Related]

  • 18. A multicentre, open study to assess the effect of individualizing starting doses of atorvastatin according to baseline LDL-C levels on achieving cholesterol targets: the Achieve Cholesterol Targets Fast with Atorvastatin Stratified Titration (ACTFAST-2) study.
    Farsang C, Athyros V, Gaw A, ACTFAST-2 investigators and Steering Committee members.
    Curr Med Res Opin; 2007 Aug 27; 23(8):1945-56. PubMed ID: 17626713
    [Abstract] [Full Text] [Related]

  • 19. Atorvastatin calcium: an addition to HMG-CoA reductase inhibitors.
    Chong PH, Seeger JD.
    Pharmacotherapy; 1997 Aug 27; 17(6):1157-77. PubMed ID: 9399600
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and safety of combination of extended release niacin and atorvastatin in patients with low levels of high density lipoprotein cholesterol.
    Harikrishnan S, Rajeev E, Tharakan JA, Titus T, Ajit Kumar VK, Sivasankaran S, Krishnamoorthy KM, Nair K.
    Indian Heart J; 2008 Aug 27; 60(3):215-22. PubMed ID: 19240310
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.